Loading organizations...
§ Private Profile · Daejeon, Taejon-jikhalsi, South Korea
Biotech company developing cell-penetrating therapeutic antibodies.
Orum Therapeutics has raised $220.8M across 4 funding rounds.
Orum Therapeutics has raised $220.8M in total across 4 funding rounds.
Orum Therapeutics has raised $220.8M across 4 funding rounds. Most recently, it raised $98.8M Other Equity in December 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 1, 2025 | $98.8M Venture Round | — | — | Announced |
| Jun 23, 2021 | $84M Series B | IMM Investment | Atinum Investment, Intervest, KB Investment, KDB | Announced |
| Jul 17, 2019 | $30M Series B | — | IMM Investment, Intervest, KB Investment, KTB Network, Smilegate Investment, Stassets Investment | Announced |
| Jun 14, 2017 | $8M Series A | — | YEO Jung Moon, M.d., Ph.d., KB Investment, LB Investment | Announced |
Orum Therapeutics has raised $220.8M in total across 4 funding rounds.
Orum Therapeutics's investors include IMM Investment, Atinum Investment, InterVest, KB Investment, KDB, KTB Network, Smilegate Investment, Stassets Investment, Yeo Jung Moon, M.D., Ph.D., LB Investment.